See more : Domino’s Pizza Group plc (DMPZF) Income Statement Analysis – Financial Results
Complete financial analysis of Galenica AG (0ROG.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Galenica AG, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- Naturgy Energy Group, S.A. (NTGY.MC) Income Statement Analysis – Financial Results
- GEPIC Energy Development Co., Ltd. (000791.SZ) Income Statement Analysis – Financial Results
- Nissou Co.,Ltd. (1444.T) Income Statement Analysis – Financial Results
- Civitas Resources, Inc. (BCEI) Income Statement Analysis – Financial Results
- Beijing Bohui Science & Technology Co., Ltd. (688004.SS) Income Statement Analysis – Financial Results
Galenica AG (0ROG.L)
About Galenica AG
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.75B | 4.01B | 3.83B | 3.48B | 3.31B | 3.17B | 3.15B | 3.01B | 2.91B | 2.83B |
Cost of Revenue | 3.36B | 3.64B | 3.48B | 3.13B | 2.93B | 2.87B | 2.83B | 2.27B | 2.20B | 2.15B |
Gross Profit | 387.60M | 374.13M | 350.55M | 349.41M | 371.87M | 303.17M | 319.42M | 733.96M | 717.25M | 678.52M |
Gross Profit Ratio | 10.35% | 9.32% | 9.14% | 10.04% | 11.25% | 9.56% | 10.16% | 24.39% | 24.61% | 24.01% |
Research & Development | 12.70M | 13.50M | 15.20M | 15.70M | 13.40M | 11.90M | 13.51M | 12.20M | 14.08M | 13.98M |
General & Administrative | 57.51M | 47.86M | 43.35M | 36.50M | 32.95M | 27.39M | 29.95M | 40.19M | 37.92M | 36.02M |
Selling & Marketing | 42.04M | 78.30M | 72.18M | 27.77M | 28.85M | 29.58M | 61.16M | 56.05M | 57.44M | 57.92M |
SG&A | 99.55M | 166.07M | 147.64M | 129.73M | 5.85M | 57.92M | 56.38M | 96.24M | 95.36M | 93.94M |
Other Expenses | 0.00 | -1.58M | -1.38M | -1.73M | -1.60M | -895.00K | -1.32M | 4.82M | 4.72M | 4.81M |
Operating Expenses | 202.29M | 181.15M | 164.22M | 147.16M | 204.01M | 190.53M | 177.73M | 619.72M | 607.12M | 573.44M |
Cost & Expenses | 3.55B | 3.82B | 3.65B | 3.28B | 3.14B | 3.06B | 3.00B | 2.89B | 2.80B | 2.72B |
Interest Income | 1.75M | 727.00K | 738.00K | 764.00K | 4.47M | 1.73M | 1.78M | 1.04M | 1.36M | 2.43M |
Interest Expense | 15.81M | 5.51M | 5.66M | 5.25M | 6.19M | 2.80M | 2.74M | 20.44M | 20.29M | 18.23M |
Depreciation & Amortization | 103.00M | 99.57M | 98.41M | 93.42M | 90.77M | 40.99M | 40.19M | 40.50M | 41.24M | 40.90M |
EBITDA | 306.92M | 290.46M | 300.34M | 302.78M | 254.69M | 147.70M | 178.39M | 160.05M | 161.15M | 156.99M |
EBITDA Ratio | 8.19% | 7.31% | 7.43% | 8.50% | 6.09% | 4.45% | 5.25% | 5.53% | 5.52% | 5.55% |
Operating Income | 191.29M | 192.98M | 186.33M | 202.25M | 163.32M | 105.69M | 130.72M | 123.82M | 118.52M | 113.75M |
Operating Income Ratio | 5.11% | 4.81% | 4.86% | 5.81% | 4.94% | 3.33% | 4.16% | 4.12% | 4.07% | 4.02% |
Total Other Income/Expenses | 3.66M | -2.75M | -11.14M | -9.22M | 78.00K | 5.22M | 9.20M | -16.91M | -15.56M | -11.44M |
Income Before Tax | 194.95M | 195.42M | 196.27M | 204.11M | 163.39M | 110.91M | 139.91M | 104.26M | 99.63M | 97.86M |
Income Before Tax Ratio | 5.20% | 4.87% | 5.12% | 5.87% | 4.94% | 3.50% | 4.45% | 3.47% | 3.42% | 3.46% |
Income Tax Expense | 29.25M | 33.77M | 34.85M | 35.88M | 38.09M | 36.76M | 21.05M | 20.90M | 18.52M | 16.00M |
Net Income | 173.60M | 165.13M | 167.68M | 172.25M | 124.99M | 147.55M | 118.80M | 83.39M | 81.12M | 81.82M |
Net Income Ratio | 4.63% | 4.11% | 4.37% | 4.95% | 3.78% | 4.65% | 3.78% | 2.77% | 2.78% | 2.90% |
EPS | 5.72 | 3.32 | 3.38 | 3.48 | 2.54 | 3.00 | 2.43 | 1.67 | 1.62 | 1.64 |
EPS Diluted | 5.72 | 3.32 | 3.38 | 3.48 | 2.53 | 3.00 | 2.42 | 1.67 | 1.62 | 1.64 |
Weighted Avg Shares Out | 49.85M | 49.73M | 49.57M | 49.43M | 49.27M | 49.11M | 48.98M | 50.00M | 50.00M | 50.00M |
Weighted Avg Shares Out (Dil) | 49.89M | 49.80M | 49.63M | 49.48M | 49.35M | 49.19M | 49.07M | 50.00M | 50.00M | 50.00M |
Source: https://incomestatements.info
Category: Stock Reports